Posters

The efficacy of pars plana vitrectomy of type 2 idiopathic macular telangiectasia with epiretinal membrane

Poster Details

First Author: S.Seong SOUTH KOREA

Co Author(s):    O. Kwon   S. Kim   Y. You   H. Oh   J. Lee   J. Kim              

Abstract Details



Purpose:

To introduce the efficacy of vitrectomy in treating type 2 idiopathic macular telangiectasia with epiretinal membrane

Setting:

Retrospective chart review of a single institution (retina centre, Nune eye Hospital)

Methods:

Six eyes of six patients with type 2 idiopathic macular telangiectasia with epiretinal membrane. Main outcome measures were best-corrected visual acuity (BCVA), presence of epiretinal membrane(ERM), intraretinal cystic change, and hyperfluorescence with leakage on fluorescein angiography. Pars plana vitrectomy with membrane peeling was performed for ERM.

Results:

Six eyes with type 2 idiopathic macular telangiectasia with epiretinal membrane were treated with pars plana vitrectomy with membrane peeling. Mean follow-up was 47.5 months (range 4 months to 6 years). Mean BCVA increased from 0.22 LogMAR to 0.12 LogMAR at the end of the follow-up. All six eyes underwent vitrectomy with membrane peeling. Epiretinal membrane and intraretina cyst were disappeared successfully in all cases. Visual acuity were improved in 5 of 6 eyes and decreased in 1 eyes. 1 eye of decreased vision was just 3 months after postoperative state.

Conclusions:

Pars plana vitrectomy in treating type 2 idiopathic macular telangiectasia with ERM has a good chance of anatomical restoration and improving vision.

Back to previous
EURETINA, Temple House, Temple Road, Blackrock, Co Dublin. | Phone: 00353 1 2100092 | Fax: 00353 1 2091112 | Email: euretina@euretina.org

Privacy policyHotel Terms and Conditions Cancellation policy